Received: 29 September 2020
Accepted: 25 January 2021
First Online: 25 February 2021
Ethics approval and consent to participate
: The study design was approved by King Abdulla Medical City Institutional Review Board (KAMC-IRB) and registered at the National BioMedical Ethics Committee, King Abdulaziz City for Science and Technology on 14-07-1433 (Registration no. H-02-K-001). <i>IRB approval document is available.</i>
: Not applicable
: None of the authors has any financial and non-financial competing interests to declare.